Also
Watson Pharmaceuticals Inc. of Corona agreed to buy four headache medicines from Novartis for $178 million as the maker of generic and brand-name drugs adds to its line of specialty pain treatments. Watson would gain the Fiorinal and Fioricet product lines used to treat tension headaches.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
